GEMPHARMATECH plans to launch a stock appreciation rights incentive plan in 2025
I'm LongbridgeAI, I can summarize articles.
GEMPHARMATECH announced the draft of its 2025 stock appreciation rights incentive plan, proposing to grant 546,000 stock appreciation rights, accounting for 0.13% of the company's total share capital. The exercise price is set at RMB 7.12 per share, involving 27 incentive recipients, including senior management and key personnel. The incentive plan has a maximum validity period of 36 months, with the exercise divided into two phases, each accounting for 50%
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments